tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:4AB Stock Latest News

Raymond James views Bretisilocin as solid addition to AbbVie’s Neuro pipeline
The FlyRaymond James views Bretisilocin as solid addition to AbbVie’s Neuro pipeline
3d ago
ABBV
AbbVie to acquire Gilgamesh’s bretisilocin program for up to $1.2B
PremiumThe Fly
AbbVie to acquire Gilgamesh’s bretisilocin program for up to $1.2B
4d ago
ABBV
AbbVie’s upadacitinib achieves endpoint in Phase 3 alopecia areata trial
PremiumThe Fly
AbbVie’s upadacitinib achieves endpoint in Phase 3 alopecia areata trial
8d ago
ABBV
AbbVie completes acquisition of Capstan Therapeutics
PremiumThe Fly
AbbVie completes acquisition of Capstan Therapeutics
10d ago
ABBV
AbbVie announces $195M investment to expand API manufacturing in U.S.
PremiumThe Fly
AbbVie announces $195M investment to expand API manufacturing in U.S.
16d ago
ABBV
Starbucks upgraded, Shopify downgraded: Wall Street’s top analyst calls
PremiumThe FlyStarbucks upgraded, Shopify downgraded: Wall Street’s top analyst calls
17d ago
AIZ
CMG
AbbVie assumed with an Overweight at Piper Sandler
Premium
The Fly
AbbVie assumed with an Overweight at Piper Sandler
17d ago
ABBV
AbbVie: Strong Buy Rating Due to Minimal LOE Risks and Growth in Key Segments
Premium
Ratings
AbbVie: Strong Buy Rating Due to Minimal LOE Risks and Growth in Key Segments
17d ago
ABBV
Regenxbio launches program for surabgene lomparvovec in diabetic retinopathy
PremiumThe Fly
Regenxbio launches program for surabgene lomparvovec in diabetic retinopathy
22d ago
ABBV
RGNX
AbbVie upgraded to Outperform from Neutral at Daiwa
PremiumThe Fly
AbbVie upgraded to Outperform from Neutral at Daiwa
22d ago
ABBV
AbbVie: Balancing Strong Earnings with Humira Challenges and External Risks
PremiumRatings
AbbVie: Balancing Strong Earnings with Humira Challenges and External Risks
24d ago
ABBV
AbbVie Shines in Earnings Call with Strong Growth
PremiumCompany Announcements
AbbVie Shines in Earnings Call with Strong Growth
27d ago
ABBV
AbbVie price target raised to $227 from $216 at Guggenheim
PremiumThe FlyAbbVie price target raised to $227 from $216 at Guggenheim
28d ago
ABBV
AbbVie price target raised to $207 from $205 at Evercore ISI
Premium
The Fly
AbbVie price target raised to $207 from $205 at Evercore ISI
28d ago
ABBV
AbbVie price target raised to $236 from $227 at Raymond James
Premium
The Fly
AbbVie price target raised to $236 from $227 at Raymond James
28d ago
ABBV
AbbVie Receives Buy Rating from Terence Flynn Due to Strong Financial Performance and Growth Potential
PremiumRatings
AbbVie Receives Buy Rating from Terence Flynn Due to Strong Financial Performance and Growth Potential
28d ago
ABBV
AbbVie: Balancing Strong Performance with Pricing Uncertainties and Valuation Concerns
PremiumRatings
AbbVie: Balancing Strong Performance with Pricing Uncertainties and Valuation Concerns
28d ago
ABBV
AbbVie Reports Strong Q2 2025 Financial Results
PremiumCompany Announcements
AbbVie Reports Strong Q2 2025 Financial Results
28d ago
ABBV
Trump posts letters calling on drug company CEOs to lower prices
PremiumThe Fly
Trump posts letters calling on drug company CEOs to lower prices
28d ago
AZN
BMY
AbbVie says ‘fairly insulated’ from any tariff impacts this year
PremiumThe FlyAbbVie says ‘fairly insulated’ from any tariff impacts this year
29d ago
ABBV
AbbVie sees Q3 adjusted EPS $3.24-$3.28, consensus $3.24
Premium
The Fly
AbbVie sees Q3 adjusted EPS $3.24-$3.28, consensus $3.24
29d ago
ABBV
AbbVie sees FY25 adjusted gross margin 84% of sales
Premium
The Fly
AbbVie sees FY25 adjusted gross margin 84% of sales
29d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >